CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-15 | GUSSIN ROBERT Z Director | Option exercise | +2,801 | $27.37 | $77K | 6,710 |
| 2021-09-15 | GUSSIN ROBERT Z Director | Shares withheld for taxes | −1,746 | $43.92 | $77K | 4,964 |
| 2021-09-15 | GUSSIN ROBERT Z Director | Option exercise · Common Stock | −2,801 | $27.37 | $77K | 0 |
| 2021-07-20 | BARBIER REMI President and CEO | Option exercise | +2,801 | $20.23 | $57K | 326,652 |
| 2021-07-20 | BARBIER REMI President and CEO | Option exercise · Common Stock | −2,801 | $20.23 | $57K | 0 |
| 2021-05-27 | BARBIER REMI President and CEO | Option exercise | +56,030 | $53.55 | $3.0M | 1,134,885 |
| 2021-05-27 | BARBIER REMI President and CEO | Shares withheld for taxes | −53,965 | $55.60 | $3.0M | 1,080,920 |
| 2021-05-27 | BARBIER REMI President and CEO | Option exercise · Common Stock | −56,030 | $53.55 | $3.0M | 0 |
| 2021-03-30 | ROBERTSON SANFORD Director | Option exercise | +2,802 | $27.37 | $77K | 915,425 |
| 2021-03-30 | ROBERTSON SANFORD Director | Option exercise | +4,670 | $49.00 | $229K | 920,095 |
| 2021-03-30 | ROBERTSON SANFORD Director | Option exercise · Common Stock | −2,802 | $27.37 | $77K | 0 |
| 2021-03-30 | ROBERTSON SANFORD Director | Option exercise · Common Stock | −4,670 | $49.00 | $229K | 0 |
| 2021-03-17 | FRIEDMANN NADAV Chief Medical Officer | Option exercise | +28,015 | $53.55 | $1.5M | 92,428 |
| 2021-03-17 | FRIEDMANN NADAV Chief Medical Officer | Shares withheld for taxes | −23,996 | $62.52 | $1.5M | 68,429 |
| 2021-03-17 | FRIEDMANN NADAV Chief Medical Officer | Option exercise · Common Stock | −28,015 | $53.55 | $1.5M | 0 |
| 2021-03-16 | O DONNELL MICHAEL J Director | Option exercise | +4,669 | $49.00 | $229K | 9,257 |
| 2021-03-16 | O DONNELL MICHAEL J Director | Shares withheld for taxes | −4,387 | $52.16 | $229K | 4,870 |
| 2021-03-16 | O DONNELL MICHAEL J Director | Option exercise · Common Stock | −4,669 | $49.00 | $229K | 0 |
| 2020-12-11 | SCANNON PATRICK J MD PHD Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2020-12-11 | GUSSIN ROBERT Z Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 8 of 17 · 324 trades